Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Share-based Compensation

v3.8.0.1
Note 8 - Share-based Compensation
3 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
8.
Share-based Compensation:
 
During the
 quarter ended
September 30, 2017
and
2016,
the Company granted 
0.6
million and
1.0
million stock options at weighted average grant prices of
$114
.60
and
$107.60
and weighted average fair values of
$20
.47
and
$17.98,
respectively. During the quarter ended
September 30, 2017
and
2016,
the Company granted 
500
and
64
,931
restricted stock units at a weighted average fair value of
$122
.57
and
$109.36,
respectively. The Company did
not
grant any shares of restricted stock during the quarter ended
September 30, 2017.
During the quarter ended
September 3
0,
2016,
the Company granted 
16,653
shares of restricted stock at a grant date fair value of
$106.59,
respectively
.
 
Stock options
for 
32
,625
and
22,145
shares of common stock with total intrinsic values of
$0.9
million and
$0.9
million were exercised during the quarter ended
September 30, 2017
and
2016,
respectively.
 
Stock-based
compensation expense of
$3
.8
million and
$3.2
million was included in selling, general and administrative expenses for the quarter ended
September 30, 2017
and
2016,
respectively. As of
September 30, 2017,
there was
$32
.5
million of unrecognized compensation cost related to non-vested stock options, non-vested restricted stock units and non-vested restricted stock. The weighted average period over which the compensation cost is expected to be recognized is 
2.6
years.